WellBeam

Overview
News
Hospital-at-Home?
Product stageSegments
Minimum Viable Product
?
Home Care Workflow
?

Wellbeam Consumer Health is a diversified portfolio of wellness brands focused on ecommerce. The company's portfolio includes TruSkin, Eu Natural, and BioTRUST, which offer various products in categories such as skincare, vitamins, minerals, nutritional supplements, protein, collagen, healthy living, anti-aging, and digestive health. Wellbeam's strategy involves expanding its ecommerce strength, building an omni-channel retail presence, and launching new product innovations. The company aims to help consumers reach their wellness goals and live healthier lives.

Wellbeam has demonstrated a history of acquiring ecommerce-based wellness brands. In 2021, the company acquired Penetrex, a joint and muscle relief brand; Eu Natural, a provider of vitamin and mineral supplements; and TruSkin, a skincare brand offering plant-powered products. In January 2022, Wellbeam further expanded its portfolio by acquiring BioTRUST Nutrition, a direct-to-consumer ecommerce nutrition brand specializing in protein, collagen, and healthy aging products. This acquisition enhanced Wellbeam's data-driven multi-channel marketing capabilities and expanded its presence in the nutritional powders segment.

Wellbeam has developed expertise in data-driven digital and ecommerce activation, consumer-centric brand management, and new product development. The company's focus on ecommerce has been a key aspect of its business model. In April 2024, Wellbeam sold its Penetrex brand to Carlin Consumer Health, indicating ongoing portfolio management and strategic decisions.


Sources

Disclaimer: This company profile has been generated using data obtained through automated web searches and advanced generative AI technology. While we strive to ensure the accuracy and reliability of our sources, auto-generated information could be outdated or inaccurate and should be verified independently.
HQ location:
Palo Alto CA USA
Founded year:
2019
Employees:
11-50
IPO status:
Private
Total funding:
USD 7.7 mn
Last Funding:
USD 7.7 mn (Series Unknown; Oct 2021)
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.